Listed

SANUWAVE Health, Inc.

SNWVNasdaqCIK 1417663HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$9.7m, Q2 FY2026
Operating income−$280.0k, Q2 FY2026
Net income−$682.0k, Q2 FY2026
SANUWAVE Health, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m4.8Revenue, Q3 FY2023, three months to 2023-09-30$4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure6.5Revenue, Q4 FY2023, three months to 2023-12-31$6.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure5.7Revenue, Q1 FY2024, three months to 2024-03-31$5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure7.1Revenue, Q2 FY2024, three months to 2024-06-30$7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure9.3Revenue, Q3 FY2024, three months to 2024-09-30$9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure10.3Revenue, Q4 FY2024, three months to 2024-12-31$10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure9.3Revenue, Q1 FY2025, three months to 2025-03-31$9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure10.1Revenue, Q2 FY2025, three months to 2025-06-30$10.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure11.4Revenue, Q3 FY2025, three months to 2025-09-30$11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure13.2Revenue, Q4 FY2025, three months to 2025-12-31$13.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure9.6Revenue, Q1 FY2026, three months to 2026-03-31$9.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure9.7Revenue, Q2 FY2026, three months to 2026-06-30$9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Cost of revenue$m1.4Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure2.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$2.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure1.6Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure1.9Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure2.3Cost of revenue, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure2.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure2.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$2.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure2.2Cost of revenue, Q2 FY2025, three months to 2025-06-30$2.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure2.5Cost of revenue, Q3 FY2025, three months to 2025-09-30$2.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure3.4Cost of revenue, Q4 FY2025, three months to 2025-12-31$3.4m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure2.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure2.3Cost of revenue, Q2 FY2026, three months to 2026-06-30$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Gross profit$m3.5Gross profit, Q3 FY2023, three months to 2023-09-30$3.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure4.8Gross profit, Q4 FY2023, three months to 2023-12-31$4.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure4.2Gross profit, Q1 FY2024, three months to 2024-03-31$4.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure5.2Gross profit, Q2 FY2024, three months to 2024-06-30$5.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure7.1Gross profit, Q3 FY2024, three months to 2024-09-30$7.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure8.0Gross profit, Q4 FY2024, three months to 2024-12-31$8.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure7.4Gross profit, Q1 FY2025, three months to 2025-03-31$7.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure7.8Gross profit, Q2 FY2025, three months to 2025-06-30$7.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure8.7Gross profit, Q3 FY2025, three months to 2025-09-30$8.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure10.0Gross profit, Q4 FY2025, three months to 2025-12-31$10.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure7.4Gross profit, Q1 FY2026, three months to 2026-03-31$7.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure7.4Gross profit, Q2 FY2026, three months to 2026-06-30$7.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Research and development$m0.2Research and development, Q3 FY2023, three months to 2023-09-30$165.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure0.1Research and development, Q4 FY2023, three months to 2023-12-31$143.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure0.2Research and development, Q1 FY2024, three months to 2024-03-31$163.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure0.2Research and development, Q2 FY2024, three months to 2024-06-30$195.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure0.2Research and development, Q3 FY2024, three months to 2024-09-30$161.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure0.2Research and development, Q4 FY2024, three months to 2024-12-31$154.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure0.2Research and development, Q1 FY2025, three months to 2025-03-31$208.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure0.2Research and development, Q2 FY2025, three months to 2025-06-30$194.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure0.3Research and development, Q3 FY2025, three months to 2025-09-30$345.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure0.6Research and development, Q4 FY2025, three months to 2025-12-31$606.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure0.7Research and development, Q1 FY2026, three months to 2026-03-31$660.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure0.6Research and development, Q2 FY2026, three months to 2026-06-30$628.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Operating income$m(0.5)Operating income, Q3 FY2023, three months to 2023-09-30−$531.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure1.0Operating income, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure(1.3)Operating income, Q1 FY2024, three months to 2024-03-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure1.6Operating income, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure1.5Operating income, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure2.0Operating income, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure0.6Operating income, Q1 FY2025, three months to 2025-03-31$601.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure1.4Operating income, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure0.9Operating income, Q3 FY2025, three months to 2025-09-30$903.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure2.0Operating income, Q4 FY2025, three months to 2025-12-31$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure(1.1)Operating income, Q1 FY2026, three months to 2026-03-31−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(0.3)Operating income, Q2 FY2026, three months to 2026-06-30−$280.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-09, accession 0001140361-23-052479.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reported0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figurenot reportednot reportednot reported0.0Income tax, Q2 FY2026, three months to 2026-06-30$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Net income$m(23.7)Net income, Q3 FY2023, three months to 2023-09-30−$23.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure18.2Net income, Q4 FY2023, three months to 2023-12-31$18.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure(4.8)Net income, Q1 FY2024, three months to 2024-03-31−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure6.2Net income, Q2 FY2024, three months to 2024-06-30$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure(21.2)Net income, Q3 FY2024, three months to 2024-09-30−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure(13.3)Net income, Q4 FY2024, three months to 2024-12-31−$13.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure(6.1)Net income, Q1 FY2025, three months to 2025-03-31−$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure0.6Net income, Q2 FY2025, three months to 2025-06-30$551.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure9.7Net income, Q3 FY2025, three months to 2025-09-30$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure7.7Net income, Q4 FY2025, three months to 2025-12-31$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure(1.4)Net income, Q1 FY2026, three months to 2026-03-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(0.7)Net income, Q2 FY2026, three months to 2026-06-30−$682.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Diluted EPS$ per share(9.95)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$9.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figurenot reported0.00Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure0.00Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure(6.65)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$6.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figurenot reported(0.72)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(0.04)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure0.39Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Basic EPS$ per share(9.95)Basic EPS, Q3 FY2023, three months to 2023-09-30−$9.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figurenot reported0.00Basic EPS, Q1 FY2024, three months to 2024-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure0.01Basic EPS, Q2 FY2024, three months to 2024-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure(6.65)Basic EPS, Q3 FY2024, three months to 2024-09-30−$6.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figurenot reported(0.72)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure0.06Basic EPS, Q2 FY2025, three months to 2025-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure1.13Basic EPS, Q3 FY2025, three months to 2025-09-30$1.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figurenot reported(0.17)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure

Balance sheet

Cash and equivalents$9.4m, Q2 FY2026
Long-term debt$14.8m, Q1 FY2026
Shareholders' equity$2.8m, Q2 FY2026
SANUWAVE Health, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m1.1Cash and equivalents, Q3 FY2023, at 2023-09-30$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001140361-23-052479.Report this figure1.8Cash and equivalents, FY2023, at 2023-12-31$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure2.9Cash and equivalents, Q1 FY2024, at 2024-03-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001140361-24-025214.Report this figure2.5Cash and equivalents, Q2 FY2024, at 2024-06-30$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0001628280-24-036760.Report this figure3.3Cash and equivalents, Q3 FY2024, at 2024-09-30$3.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure10.2Cash and equivalents, FY2024, at 2024-12-31$10.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure8.5Cash and equivalents, Q1 FY2025, at 2025-03-31$8.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure8.5Cash and equivalents, Q2 FY2025, at 2025-06-30$8.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure9.6Cash and equivalents, Q3 FY2025, at 2025-09-30$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure12.0Cash and equivalents, FY2025, at 2025-12-31$12.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure10.8Cash and equivalents, Q1 FY2026, at 2026-03-31$10.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure9.4Cash and equivalents, Q2 FY2026, at 2026-06-30$9.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Current assets$m7.4Current assets, Q3 FY2023, at 2023-09-30$7.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001140361-23-052479.Report this figure9.8Current assets, FY2023, at 2023-12-31$9.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure10.8Current assets, Q1 FY2024, at 2024-03-31$10.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001140361-24-025214.Report this figure8.7Current assets, Q2 FY2024, at 2024-06-30$8.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001628280-24-036760.Report this figure9.9Current assets, Q3 FY2024, at 2024-09-30$9.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure18.4Current assets, FY2024, at 2024-12-31$18.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure18.8Current assets, Q1 FY2025, at 2025-03-31$18.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure20.2Current assets, Q2 FY2025, at 2025-06-30$20.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure22.6Current assets, Q3 FY2025, at 2025-09-30$22.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure24.6Current assets, FY2025, at 2025-12-31$24.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure24.0Current assets, Q1 FY2026, at 2026-03-31$24.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure23.2Current assets, Q2 FY2026, at 2026-06-30$23.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Total assets$m20.3Total assets, Q3 FY2023, at 2023-09-30$20.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001140361-23-052479.Report this figure22.4Total assets, FY2023, at 2023-12-31$22.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure23.3Total assets, Q1 FY2024, at 2024-03-31$23.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001140361-24-025214.Report this figure21.0Total assets, Q2 FY2024, at 2024-06-30$21.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001628280-24-036760.Report this figure21.8Total assets, Q3 FY2024, at 2024-09-30$21.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure30.1Total assets, FY2024, at 2024-12-31$30.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure30.9Total assets, Q1 FY2025, at 2025-03-31$30.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure33.0Total assets, Q2 FY2025, at 2025-06-30$33.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure35.6Total assets, Q3 FY2025, at 2025-09-30$35.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure37.3Total assets, FY2025, at 2025-12-31$37.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure37.1Total assets, Q1 FY2026, at 2026-03-31$37.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure36.6Total assets, Q2 FY2026, at 2026-06-30$36.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Current liabilities$m85.4Current liabilities, Q3 FY2023, at 2023-09-30$85.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001140361-23-052479.Report this figure64.8Current liabilities, FY2023, at 2023-12-31$64.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure70.2Current liabilities, Q1 FY2024, at 2024-03-31$70.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001140361-24-025214.Report this figure60.0Current liabilities, Q2 FY2024, at 2024-06-30$60.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001628280-24-036760.Report this figure81.5Current liabilities, Q3 FY2024, at 2024-09-30$81.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure45.4Current liabilities, FY2024, at 2024-12-31$45.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure50.8Current liabilities, Q1 FY2025, at 2025-03-31$50.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure50.4Current liabilities, Q2 FY2025, at 2025-06-30$50.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure24.0Current liabilities, Q3 FY2025, at 2025-09-30$24.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure17.8Current liabilities, FY2025, at 2025-12-31$17.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure18.3Current liabilities, Q1 FY2026, at 2026-03-31$18.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure18.2Current liabilities, Q2 FY2026, at 2026-06-30$18.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Total liabilities$m86.3Total liabilities, Q3 FY2023, at 2023-09-30$86.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001140361-23-052479.Report this figure65.6Total liabilities, FY2023, at 2023-12-31$65.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure70.9Total liabilities, Q1 FY2024, at 2024-03-31$70.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001140361-24-025214.Report this figure60.6Total liabilities, Q2 FY2024, at 2024-06-30$60.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001628280-24-036760.Report this figure82.1Total liabilities, Q3 FY2024, at 2024-09-30$82.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure45.9Total liabilities, FY2024, at 2024-12-31$45.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure51.7Total liabilities, Q1 FY2025, at 2025-03-31$51.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure51.8Total liabilities, Q2 FY2025, at 2025-06-30$51.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure43.2Total liabilities, Q3 FY2025, at 2025-09-30$43.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure35.7Total liabilities, FY2025, at 2025-12-31$35.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure35.3Total liabilities, Q1 FY2026, at 2026-03-31$35.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure33.8Total liabilities, Q2 FY2026, at 2026-06-30$33.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported17.5Long-term debt, Q3 FY2025, at 2025-09-30$17.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure16.1Long-term debt, FY2025, at 2025-12-31$16.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure14.8Long-term debt, Q1 FY2026, at 2026-03-31$14.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figurenot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported5.8Current portion of debt, Q3 FY2025, at 2025-09-30$5.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure5.8Current portion of debt, FY2025, at 2025-12-31$5.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure5.8Current portion of debt, Q1 FY2026, at 2026-03-31$5.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figurenot reported
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(66.0)Shareholders' equity, Q3 FY2023, at 2023-09-30−$66.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure(44.5)Shareholders' equity, FY2023, at 2023-12-31−$44.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure(47.6)Shareholders' equity, Q1 FY2024, at 2024-03-31−$47.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure(39.6)Shareholders' equity, Q2 FY2024, at 2024-06-30−$39.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure(60.3)Shareholders' equity, Q3 FY2024, at 2024-09-30−$60.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure(15.8)Shareholders' equity, FY2024, at 2024-12-31−$15.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure(20.8)Shareholders' equity, Q1 FY2025, at 2025-03-31−$20.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure(18.8)Shareholders' equity, Q2 FY2025, at 2025-06-30−$18.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure(7.6)Shareholders' equity, Q3 FY2025, at 2025-09-30−$7.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure1.6Shareholders' equity, FY2025, at 2025-12-31$1.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure1.8Shareholders' equity, Q1 FY2026, at 2026-03-31$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure2.8Shareholders' equity, Q2 FY2026, at 2026-06-30$2.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure

Cash flow

Operating cash flow$425.0k, Q2 FY2026
Capital expenditure$334.0k, Q2 FY2026
SANUWAVE Health, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(2,038)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001628280-24-046396. Derived: 9-month figure less the 6-month figure.Report this figure(1,285)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure1,100Operating cash flow, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure(668)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$668.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 6-month figure less the 3-month figure.Report this figure1,282Operating cash flow, Q3 FY2024, three months to 2024-09-30$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 9-month figure less the 6-month figure.Report this figure741Operating cash flow, Q4 FY2024, three months to 2024-12-31$741.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure(1,517)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure993Operating cash flow, Q2 FY2025, three months to 2025-06-30$993.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Report this figure1,081Operating cash flow, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 9-month figure less the 6-month figure.Report this figure3,319Operating cash flow, Q4 FY2025, three months to 2025-12-31$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure397Operating cash flow, Q1 FY2026, three months to 2026-03-31$397.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure425Operating cash flow, Q2 FY2026, three months to 2026-06-30$425.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001628280-24-046396. Derived: 9-month figure less the 6-month figure.Report this figure(169)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$169.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure114Capital expenditure, Q1 FY2024, three months to 2024-03-31$114.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure92.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$92.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001628280-25-038937. Derived: 6-month figure less the 3-month figure.Report this figure48.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$48.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001628280-25-050280. Derived: 9-month figure less the 6-month figure.Report this figure236Capital expenditure, Q4 FY2024, three months to 2024-12-31$236.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure162Capital expenditure, Q1 FY2025, three months to 2025-03-31$162.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure1,159Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Report this figure525Capital expenditure, Q3 FY2025, three months to 2025-09-30$525.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001628280-25-050280. Derived: 9-month figure less the 6-month figure.Report this figure96.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$96.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure23.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure334Capital expenditure, Q2 FY2026, three months to 2026-06-30$334.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)8.60m, Q2 FY2026
SANUWAVE Health, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares561Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30561,069,625 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001140361-23-052479.Report this figure575Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31575,028,811 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001140361-24-025214.Report this figure582Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30582,329,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0001628280-24-036760.Report this figure2.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-302,381,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001628280-24-046396.Report this figure3.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-313,099,335 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure3.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-303,699,501 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure3.2Diluted shares (weighted), Q3 FY2024, three months to 2024-09-303,185,495 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure8.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,547,675 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure9.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-309,167,846 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure9.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-309,140,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure8.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-318,591,098 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure8.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-308,601,198 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure

Shares outstanding: 8.60mShares outstanding, period not labelled, at 2026-08-048,602,309 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.